RUPRI Health Panel Provided Comments to CMS-4192-P: Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs. February 2022.
Read Comment Letter Here
RUPRI Health Panel Provides Comments to CMS on Policy and Technical Changes to Medicare Advantage and Medicare Prescription Drug Benefit Programs for Contract Year 2023. February 2022.
RUPRI Health Panel Provided Comments to CMS-4192-P: Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs. February 2022.
Read Comment Letter Here